NEW YORK (GenomeWeb News) — Ipsogen said today it has received ISO 13485 certification covering the manufacture and sale of in vitro diagnostic medical devices at its headquarters in Marseille, France.
 
The certification covers Ipsogen’s blood-based IVDs for molecular analysis, diagnosis, prognosis, and follow-ups in cancer patients.
 
Ipsogen CEO Vincent Fert said the certification shows “compliance with a significant part of the FDA Quality System Regulation."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.